Myriad Genetics (NASDAQ:MYGN) Price Target Cut to $20.00 by Analysts at Scotiabank
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its target price lowered by Scotiabank from $24.00 to $20.00 in a note ...
6MYGN : 10 Analysts Assess Myriad Genetics: What You Need To Know
Analysts have recently evaluated Myriad Genetics and provided 12-month price targets. The average target is $17.1, ...
Myriad Genetics price target lowered to $20 from $24 at Scotiabank
Scotiabank lowered the firm’s price target on Myriad Genetics (MYGN) to $20 from $24 and keeps an Outperform rating on the shares. The firm ...
Myriad Genetics (MYGN) Receives a Buy from Scotiabank
Scotiabank analyst Sung Ji Nam maintained a Buy rating on Myriad Genetics (MYGN – Research Report) today and set a price target of $20.00. The ...
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Recommendation of “Hold” by Brokerages
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned a consensus rating of “Hold” from the fifteen ...
Yahoo Finance22d
Why Are Myriad Genetics (MYGN) Shares Soaring Today
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 10.6% in the morning session after Piper Sandler analysts upgraded the stock's rating from Neutral to Buy. The improved ...
Yahoo Finance6d
Is Myriad Genetics Stock Worth Holding in Your Portfolio Now?
Myriad Genetics, Inc.’s MYGN Oncology growth strategy, which focuses on expanding companion diagnostics and market growth through new clinical guidelines, is poised to drive growth in the ...
CNN22d
Myriad Genetics, Inc.
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics ...
Nasdaq2d
10 Analysts Assess Myriad Genetics: What You Need To Know
In the preceding three months, 10 analysts have released ratings for Myriad Genetics (NASDAQ:MYGN), presenting a wide array of perspectives from bullish to bearish. Summarizing their recent ...